Literature DB >> 24659496

Nuclear protein spreading: implication for pathophysiology of neuromuscular diseases.

Maxime Ferreboeuf1, Virginie Mariot1, Denis Furling1, Gillian Butler-Browne1, Vincent Mouly1, Julie Dumonceaux2.   

Abstract

While transfer of a protein encoded by a single nucleus to nearby nuclei in multinucleated cells has been known for almost 25 years, the biological consequences for gain-of-function diseases have not been considered. Here, we have investigated nuclear protein spreading and its potential consequences in two of the three most prevalent neuromuscular diseases. By performing co-cultures between diseased or control human myoblasts and murine C2C12 myoblasts, we demonstrate that in facioscapulohumeral dystrophy, although the transcription of the toxic protein DUX4 occurs in only a limited number of nuclei, the resulting protein diffuses into nearby nuclei within the myotubes, thus spreading aberrant gene expression. In myotonic dystrophy type 1, we observed that in human-mouse heterokaryons, the expression of a mutated DMPK from human nuclei titrates splicing factors produced by neighboring nuclei, inducing the mis-splicing of several pre-mRNAs in murine nuclei. In both cases, the spreading of the pathological phenotypes from one nucleus to another is observed, highlighting an additional mechanism that contributes to the dissemination and worsening of the muscle pathogenesis. These results indicate that nuclear protein spreading may be an important component of pathophysiology of gain of function muscular diseases which should be taken into consideration in the design of new therapeutic approaches.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24659496     DOI: 10.1093/hmg/ddu129

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  14 in total

1.  Single-cell RNA sequencing in facioscapulohumeral muscular dystrophy disease etiology and development.

Authors:  Anita van den Heuvel; Ahmed Mahfouz; Susan L Kloet; Judit Balog; Baziel G M van Engelen; Rabi Tawil; Stephen J Tapscott; Silvère M van der Maarel
Journal:  Hum Mol Genet       Date:  2019-04-01       Impact factor: 6.150

2.  Relationship of DUX4 and target gene expression in FSHD myocytes.

Authors:  Jonathan Chau; Xiangduo Kong; Nam Viet Nguyen; Katherine Williams; Miya Ball; Rabi Tawil; Tohru Kiyono; Ali Mortazavi; Kyoko Yokomori
Journal:  Hum Mutat       Date:  2021-02-04       Impact factor: 4.878

3.  Expression of FSHD-related DUX4-FL alters proteostasis and induces TDP-43 aggregation.

Authors:  Sachiko Homma; Mary Lou Beermann; Frederick M Boyce; Jeffrey Boone Miller
Journal:  Ann Clin Transl Neurol       Date:  2015-01-15       Impact factor: 4.511

4.  Skeletal muscle characteristics are preserved in hTERT/cdk4 human myogenic cell lines.

Authors:  Matthew Thorley; Stéphanie Duguez; Emilia Maria Cristina Mazza; Sara Valsoni; Anne Bigot; Kamel Mamchaoui; Brennan Harmon; Thomas Voit; Vincent Mouly; William Duddy
Journal:  Skelet Muscle       Date:  2016-12-08       Impact factor: 4.912

5.  Transplantation studies reveal internuclear transfer of toxic RNA in engrafted muscles of myotonic dystrophy 1 mice.

Authors:  Ricardo Mondragon-Gonzalez; Karim Azzag; Sridhar Selvaraj; Ami Yamamoto; Rita C R Perlingeiro
Journal:  EBioMedicine       Date:  2019-08-21       Impact factor: 11.205

6.  RNAscope in situ hybridization-based method for detecting DUX4 RNA expression in vitro.

Authors:  Gholamhossein Amini Chermahini; Afrooz Rashnonejad; Scott Q Harper
Journal:  RNA       Date:  2019-06-17       Impact factor: 4.942

7.  Rapid no-wash labeling of PYP-tag proteins with reactive fluorogenic ligands affords stable fluorescent protein conjugates for long-term cell imaging studies.

Authors:  Naresh Kumar; Yuichiro Hori; Miyako Nishiura; Kazuya Kikuchi
Journal:  Chem Sci       Date:  2020-03-09       Impact factor: 9.825

8.  CRISPR mediated targeting of DUX4 distal regulatory element represses DUX4 target genes dysregulated in Facioscapulohumeral muscular dystrophy.

Authors:  Sunny Das; Brian P Chadwick
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

Review 9.  Targeting the Polyadenylation Signal of Pre-mRNA: A New Gene Silencing Approach for Facioscapulohumeral Dystrophy.

Authors:  Anne-Charlotte Marsollier; Romain Joubert; Virginie Mariot; Julie Dumonceaux
Journal:  Int J Mol Sci       Date:  2018-05-03       Impact factor: 5.923

Review 10.  DUX4 Expression in FSHD Muscles: Focus on Its mRNA Regulation.

Authors:  Eva Sidlauskaite; Laura Le Gall; Virginie Mariot; Julie Dumonceaux
Journal:  J Pers Med       Date:  2020-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.